Caveats of mesenchymal stem cell therapy in solid organ transplantation

Transplant International

Volumn 28, Issue 1, 2015, Pages 1-9

  Haarer, Jan ^a   Johnson, Christian L ^a   Soeder, Yorick ^a   Dahlke, Marc H ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

mesenchymal stem cells; risks; solid organ transplantation; stromal cells

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

CARCINOGENESIS; CELL DIFFERENTIATION; GENE DOSAGE; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STEM CELL TRANSPLANTATION; MINOR HISTOCOMPATIBILITY COMPLEX; ORGAN TRANSPLANTATION; REVIEW; RISK FACTOR; TUMOR GROWTH; UNRELATED DONORS; ADVERSE EFFECTS; ANIMAL; CLINICAL TRIAL (TOPIC); CYTOLOGY; DISEASE COURSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNE SYSTEM; MESENCHYMAL STROMA CELL; MOUSE; NEOPLASMS; NEOVASCULARIZATION (PATHOLOGY); PROCEDURES;

ANIMALS; CELL DIFFERENTIATION; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; ORGAN TRANSPLANTATION;

EID: 84916599780     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12415     Document Type: Review

References (72)

1. Pittenger MF,. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143.
2. Woodbury D, Schwarz EJ, Prockop DJ, Black IB,. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000; 61: 364.
3. Wakitani S, Saito T, Caplan AI,. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995; 18: 1417.
4. Anjos-Afonso F, Siapati EK, Bonnet D,. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci 2004; 117: 5655.
5. Lee ST, Jang JH, Cheong J-W, et al,. Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol 2002; 118: 1128.
6. Wu Y, Chen L, Scott PG, Tredget EE,. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007; 25: 2648.
7. Barry FP, Murphy JM, English K, Mahon BP,. Immunogenicity of adult mesenchymal stem cells: lessons from the fetal allograft. Stem Cell Dev 2005; 14: 252.
8. Reinders ME, de Fijter JW, Roelofs H, et al,. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl Med 2013; 2: 107.
9. Breitbach M, Bostani T, Roell W, et al,. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007; 110: 1362.
10. Perico N, Casiraghi F, Gotti E, et al,. Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation. Transpl Int 2013; 26: 867.
11. Miura M, Miura Y, Padilla-Nash HM, et al,. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 2006; 24: 1095.
12. Popp FC, Eggenhofer E, Renner P, et al,. Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate. Transpl Immunol 2008; 20: 55.
13. Ge W, Jiang J, Baroja ML, et al,. Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am J Transplant 2009; 9: 1760.
14. Rafii S, Lyden D,. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003; 9: 702.
15. Zhou YF, Bosch-Marce M, Okuyama H, et al,. Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. Cancer Res 2006; 66: 10849.
16. Tasso R, Augello A, Carida M, et al,. Development of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds. Carcinogenesis 2009; 30: 150.
17. Hall B, Andreeff M, Marini F,. The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb Exp Pharmacol 2007; 180: 263.
18. Ramasamy R, Lam EW, Soeiro I, Tisato V, Bonnet D, Dazzi F,. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia 2007; 21: 304.
19. Wimmer CD, Angele MK, Schwarz B, et al,. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients. Transpl Int 2013; 26: 999.
20. Dominici M, Le Blanc K, Mueller I, et al,. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315.
21. Grisendi G, Anneren C, Cafarelli L, et al,. GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. Cytotherapy 2010; 12: 466.
22. Valim V, Amorin B, Pezzi A, Aparecida Lima da Silva M, Paula Alegretti A, Silla L,. Optimization of the cultivation of donor mesenchymal stromal cells for clinical use in cellular therapy. CellBio 2014; 03: 25.
23. Roemeling-van Rhijn M, de Klein A, Douben H, et al,. Culture expansion induces non-tumorigenic aneuploidy in adipose tissue-derived mesenchymal stromal cells. Cytotherapy 2013; 15: 1352.
24. Tolar J, Nauta AJ, Osborn MJ, et al,. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007; 25: 371.
25. Aguilar S, Nye E, Chan J, et al,. Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung. Stem Cells 2007; 25: 1586.
26. Rubio D, Garcia-Castro J, Martin MC, et al,. Spontaneous human adult stem cell transformation. Cancer Res 2005; 65: 3035.
27. Meza-Zepeda LA, Noer A, Dahl JA, Micci F, Myklebost O, Collas P,. High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence. J Cell Mol Med 2008; 12: 553.
28. Dahl JA, Duggal S, Coulston N, et al,. Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum. Int J Dev Biol 2008; 52: 1033.
29. Xiao W, Mohseny AB, Hogendoorn PC, Cleton-Jansen AM,. Mesenchymal stem cell transformation and sarcoma genesis. Clin Sarcoma Res 2013; 3: 10.
30. Casiraghi F, Remuzzi G, Abbate M, Perico N,. Multipotent mesenchymal stromal cell therapy and risk of malignancies. Stem Cell Rev 2013; 9: 65.
31. Karnoub AE, Dash AB, Vo AP, et al,. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449: 557.
32. Djouad F, Plence P, Bony C, et al,. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003; 102: 3837.
33. Ning H, Yang F, Jiang M, et al,. The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia 2008; 22: 593.
34. Baron F, Lechanteur C, Willems E, et al,. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biol Blood Marrow Transplant 2010; 16: 838.
35. Roodhart JM, Daenen LG, Stigter EC, et al,. Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids. Cancer Cell 2011; 20: 370.
36. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R,. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003; 101: 2999.
37. Liechty KW, MacKenzie TC, Shaaban AF, et al,. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000; 6: 1282.
38. Lopez-Iglesias P, Blazquez-Martinez A, Fernandez-Delgado J, Regadera J, Nistal M, Miguel MP,. Short and long term fate of human AMSC subcutaneously injected in mice. World J Stem Cells 2011; 3: 53.
39. Helczynska K, Kronblad A, Jogi A, et al,. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res 2003; 63: 1441.
40. Jogi A, Ora I, Nilsson H, et al,. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA 2002; 99: 7021.
41. Pine SR, Ryan BM, Varticovski L, Robles AI, Harris CC,. Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proc Natl Acad Sci USA 2010; 107: 2195.
42. Nobta M, Tsukazaki T, Shibata Y, et al,. Critical regulation of bone morphogenetic protein-induced osteoblastic differentiation by Delta1/Jagged1-activated Notch1 signaling. J Biol Chem 2005; 280: 15842.
43. Niwa H, Miyazaki J, Smith AG,. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000; 24: 372.
44. Pietras A, von Stedingk K, Lindgren D, Pahlman S, Axelson H,. JAG2 induction in hypoxic tumor cells alters Notch signaling and enhances endothelial cell tube formation. Mol Cancer Res 2011; 9: 626.
45. Chavali PL, Saini RK, Matsumoto Y, Agren H, Funa K,. Nuclear orphan receptor TLX induces Oct-3/4 for the survival and maintenance of adult hippocampal progenitors upon hypoxia. J Biol Chem 2011; 286: 9393.
46. Sheehy EJ, Buckley CT, Kelly DJ,. Oxygen tension regulates the osteogenic, chondrogenic and endochondral phenotype of bone marrow derived mesenchymal stem cells. Biochem Biophys Res Commun 2012; 417: 305.
47. Volkmer E, Kallukalam BC, Maertz J, et al,. Hypoxic preconditioning of human mesenchymal stem cells overcomes hypoxia-induced inhibition of osteogenic differentiation. Tissue Eng Part A 2010; 16: 153.
48. Storb R, Epstein RB, Rudolph RH, Thomas ED,. The effect of prior transfusion on marrow grafts between histocompatible canine siblings. J Immunol 1970; 105: 627.
49. Storb R, Prentice RL, Thomas ED,. Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. N Engl J Med 1977; 296: 61.
50. Schafer R, Schnaidt M, Klaffschenkel RA, et al,. Expression of blood group genes by mesenchymal stem cells. Br J Haematol 2011; 153: 520.
51. Moll G, Hult A, von Bahr L, et al,. Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells? PLoS ONE 2014; 9: e85040.
52. Sundin M, Ringden O, Sundberg B, Nava S, Gotherstrom C, Le Blanc K,. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 2007; 92: 1208.
53. Horwitz EM, Gordon PL, Koo WK, et al,. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 2002; 99: 8932.
54. Eliopoulos N, Stagg J, Lejeune L, Pommey S, Galipeau J,. Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 2005; 106: 4057.
55. Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE,. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 2006; 108: 2114.
56. Griffin MD, Ritter T, Mahon BP,. Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum Gene Ther 2010; 21: 1641.
57. Badillo AT, Beggs KJ, Javazon EH, Tebbets JC, Flake AW,. Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response. Biol Blood Marrow Transplant 2007; 13: 412.
58. Cho PS, Messina DJ, Hirsh EL, et al,. Immunogenicity of umbilical cord tissue derived cells. Blood 2008; 111: 430.
59. Popp FC, Fillenberg B, Eggenhofer E, et al,. Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation-a phase I study (MISOT-I). J Transl Med 2011; 9: 124.
60. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F,. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005; 105: 2821.
61. Li Y, Hisha H, Inaba M, et al,. Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts. Exp Hematol 2000; 28: 950.
62. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O,. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31: 890.
63. Roemeling-van Rhijn M, Reinders ME, Franquesa M, et al,. Human allogeneic bone marrow and adipose tissue derived mesenchymal stromal cells induce CD8+ cytotoxic T cell reactivity. J Stem Cell Res Ther 2013; 3: 004.
64. Heiskanen A, Hirvonen T, Salo H, et al,. Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage. Glycoconj J 2009; 26: 367.
65. Liu H, Kemeny DM, Heng BC, Ouyang HW, Melendez AJ, Cao T,. The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells. J Immunol 2006; 176: 2864.
66. Tan J, Wu W, Xu X, et al,. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA 2012; 307: 1169.
67. Gonzalo-Daganzo R, Regidor C, Martin-Donaire T, et al,. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults. Cytotherapy 2009; 11: 278.
68. Lazarus HM, Koc ON, Devine SM, et al,. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005; 11: 389.
69. Moermans C, Lechanteur C, Baudoux E, et al,. Impact of cotransplantation of mesenchymal stem cells on lung function after unrelated allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning. Transplantation 2014; 98: 348.
70. Han Z, Jing Y, Xia Y, et al,. Mesenchymal stem cells contribute to the chemoresistance of hepatocellular carcinoma cells in inflammatory environment by inducing autophagy. Cell Biosci 2014; 4: 22.
71. Jacamo R, Chen Y, Wang Z, et al,. Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-kappaB mediates chemoresistance. Blood 2014; 123: 2691.
72. Seifert M, Stolk M, Polenz D, Volk HD,. Detrimental effects of rat mesenchymal stromal cell pre-treatment in a model of acute kidney rejection. Front Immunol 2012; 3: 202.